Table 4.
Investigated Parameter | Test | Overall p-Value |
---|---|---|
Time from the onset of symptoms to surgery (hours) | KW | <0.001 |
FSH a (mU/mL) | KW | 0.003 |
Round cell count (million/mL) | KW | 0.002 |
Leukocytes (million) | KW | 0.040 |
Age at surgery (years) | KW | 0.167 |
Age at control (years) | KW | 0.704 |
Follow-up (months) | KW | 0.441 |
Height of the patient (m) | KW | 0.455 |
Weight of the patient (kg) | KW | 0.535 |
BMI b (kg/m2) | KW | 0.973 |
IIEF-5 c | KW | 0.985 |
Size of the unaffected testicle (mL) | KW | 0.318 |
Fitness scale from 1 to 5 (5 denotes the best) | KW | 0.691 |
LH d (mU/mL) | KW | 0.094 |
Testosterone (ng/mL) | KW | 0.073 |
Free testosterone (pg/mL) | KW | 0.123 |
Prolactin (µU/mL) | KW | 0.092 |
SHBG e (nmol/L) | KW | 0.737 |
Albumin (g/dL) | KW | 0.084 |
TSH f (mU/L) | KW | 0.895 |
Sperm concentration (million/mL) | KW | 0.466 |
Total sperm count (million) | KW | 0.593 |
Vitality (%) | KW | 0.239 |
Progressive motility (a+b) (%) | KW | 0.885 |
Overall motility (a+b+c+) (%) | KW | 0.465 |
Fast progressive motility (a; %) | KW | 0.798 |
Slow progressive motility (b; %) | KW | 0.391 |
Non-progressive motility (c; %) | KW | 0.559 |
Immotility (d; %) | KW | 0.455 |
Semen-pH | KW | 0.385 |
Morphology (%) | KW | 0.773 |
Oxidative stress g (mV/106 mL) | KW | 0.764 |
Spermiogram categories | KW | 0.183 |
Side of the affected testis | Chi | 0.356 |
Children fathered after testicular torsion | Chi | 0.453 |
Smoking (yes/no) | Chi | 0.126 |
Alcohol consumption (yes/no) | Chi | 0.604 |
Medication history (yes/no) | Chi | 0.399 |
Drug use (yes/no) | Chi | 0.464 |
Symptoms in the operated testis | Chi | 0.884 |
Sports activities (yes/no) | Chi | 0.026 |
Family history of testicular torsion | Chi | >0.999 |
Fitness status (yes or no) | Chi | 0.575 |
Activity at the onset of symptoms | Chi | 0.807 |
The Kruskal–Wallis (KW) test or the chi test was used for statistical analysis. a follicle-stimulating hormone; b body mass index; c International Index of Erectile Function; d luteinizing hormone; e sexual hormone binding globulin; f thyroid-stimulating hormone; g measured with the Male infertility Oxidative System (MyOxSIS).